The major features of levamisole immunotherapy are distilled from experiences gained so
far. The biochemical effects of levamisole are discussed in view of its effects on T …

Levamisole is a synthetic, orally active immunomodifier. Although it does not generally
influence normal immune reactivity, it is capable of restoring to normal levels depressed …

Twenty-six controlled prognostic evaluations of the adjuvant use of levamisole in cancer are
reviewed. The results favor intermittent administration of levamisole in a dosage that is …

Levamisole was administered to 177 patients with gastrointestinal cancer (88 curative
resection, 58 noncurative resection and 31 without resection). It was administered at a daily …

Summary Levamisole (1.1–3.8 mg/kg daily) or a placebo was given in a randomized, double-
blind study to 211 patients undergoing curative surgery for primary lung cancer. The …

Anthelmintic resistance is an accompaniment to modern livestock industry, which heavily
relies on chemotherapy and chemoprophylaxis for maintaining animal health and …

It is now well established that many cancer patients exhibit in-vivo and in-vitro evidence of
immune suppression, which often correlates with tumor-cell burden, stage of disease, and …

Ninety-nine gastric cancer patients initially received levamisole at a daily dose of 150 mg for
three consecutive days before operation. This therapy was repeated fortnightly (3-day …

Immunological profile of levamisole and its clinical application in man | SpringerLink Skip to
main content Advertisement SpringerLink Account Menu Find a journal Publish with us Track …

Human leukemic B-cell (BALL-1), T-cell (TALL-1) and null-cell (NALL-1) lines have been
established from three patients with acute lymphoblastic leukemia (ALL). To study the …